Posts Tagged ‘Ken Walz’



Staying Productive ­– Virtually

February 28th, 2011
Posted by

If you’ve ever missed a connection because of a delayed flight, or been stuck in traffic for hours, you understand one of my biggest pet peeves: inefficient use of time.
 
Because we – and our clients – are spread around the world, we use a variety of tools to keep us productive and efficient from virtually any location. These tools allow us to work remotely and sometimes they even eliminate the need for commuting or travel.
 
Some tools that we use include:

FacebookTwitterGoogle+Share

Tags: , , , , , ,
Posted in Our Views | No Comments »





Reflecting on J.P. Morgan 29th Annual Healthcare Conference

January 17th, 2011
Posted by

As one of the nearly 8,500 attendees at this year’s J.P. Morgan Healthcare Conference, I’m not alone in recording my observations. However, while the crowds and the climate are still fresh in my mind, I didn’t want to miss the opportunity to share some of my key takeaways. If you were there, please feel free to add your thoughts to the comments section. If you weren’t, let me know if you have any questions about a point I’ve made or curiosity you had about the conference that I haven’t covered.
 
Also, whether you attended or not, you may want to check out the ruminations of TheStreet.com’s Adam Feuerstein who blogged “live” from the conference as well as In Vivo’s Blog on the subject and the prose of the IR Report’s Dominic Jones.
 
My observations:
  Read the rest of this entry »

Tags: , , , , , , ,
Posted in Our Views | No Comments »





Health Care: Thoughts on Burrill’s 2011 “Converging Technology” Prognostication

January 4th, 2011
Posted by

When it comes to the life science industry, many have made 2011 predictions, including renowned biotech specialist, venture capitalist, and frequent public speaker Steve Burrill. It’s not all that surprising that he envisions much of what will happen in the year ahead will be based upon an environment that favors risk-mitigated companies, emerging biotechnology markets (e.g., Brazil and China), and challenges due to U.S. healthcare reform.
 
While I encourage you to take a look at his full list of predictions, I’m most interested in those that tie to some of the topics we’ve been discussing since we launched this blog in November, especially with regard to converging technologies.
 
Read the rest of this entry »

Tags: , , , , , , ,
Posted in Our Views | No Comments »